Log in to save to my catalogue

Epidermal growth factor receptor inhibition with erlotinib partially prevents cisplatin-induced neph...

Epidermal growth factor receptor inhibition with erlotinib partially prevents cisplatin-induced neph...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_1623315034

Epidermal growth factor receptor inhibition with erlotinib partially prevents cisplatin-induced nephrotoxicity in rats

About this item

Full title

Epidermal growth factor receptor inhibition with erlotinib partially prevents cisplatin-induced nephrotoxicity in rats

Publisher

United States: Public Library of Science

Journal title

PloS one, 2014-11, Vol.9 (11), p.e111728-e111728

Language

English

Formats

Publication information

Publisher

United States: Public Library of Science

More information

Scope and Contents

Contents

The effects of blocking the epidermal growth factor receptor (EGFR) in acute kidney injury (AKI) are controversial. Here we investigated the renoprotective effect of erlotinib, a selective tyrosine kinase inhibitor that can block EGFR activity, on cisplatin (CP)-induced AKI. Groups of animals were given either erlotinib or vehicle from one day befo...

Alternative Titles

Full title

Epidermal growth factor receptor inhibition with erlotinib partially prevents cisplatin-induced nephrotoxicity in rats

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_plos_journals_1623315034

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_1623315034

Other Identifiers

ISSN

1932-6203

E-ISSN

1932-6203

DOI

10.1371/journal.pone.0111728

How to access this item